Head and neck cancer encompass a wide variety of malignancies, including the mouth, throat, larynx, sinuses and salivary glands. Although lumps and swelling are some of the most common early warning signs, they don’t always equate to cancer.
With that said, there are other symptoms that may signal head and neck cancer, making it crucial to pay attention to our body. Read on to find out more!
Head and neck cancer encompasses a group of cancers that originate in the mouth, throat, sinuses, and salivary glands. These areas are lined with mucosal surfaces, where abnormal cell growth can occur, leading to cancer. The types of head and neck cancer include:
Head and neck cancer are categorised based on its point origin. This includes:
Lumps associated with head and neck cancers differ from benign lumps like cysts in several notable ways:
Feature | Head and Neck Cancer | Benign Lumps (Cysts and Nodules) |
Duration | Stays the same or keeps growing, doesn’t shrink. | May shrink, grow, or disappear over time. |
Texture & firmness | Hard, firm, doesn’t move when touched. | Soft or rubbery, can often be moved under the skin. |
Pain | Usually painless at first, but may hurt as it grows in size. | Can be tender or painful, especially if red and inflamed. |
Growth rate | Slow and steady growth | May change in size, but often temporary |
Other symptoms | Voice hoarseness, swallowing problems, ear pain or unexplained weight loss | Generally no serious symptoms unless infection occurs. |
Location & risks | More common in the throat, mouth, jaw or neck. | Can appear anywhere |
It’s always best to be on the safe side when it comes to your health. Seek medical attention if you experience persistent or concerning symptoms because early detection can make all the difference. Similarly, it is essential to pay particular attention to multiple symptoms occurring simultaneously, such as lumps, unexplained bleeding or chronic pain.
In Singapore, head and neck is fairly common, with more than 800 new cases [1] are diagnosed annually. The most prevalent type is nasopharyngeal carcinoma (NPC), which is often referred to as nose cancer. In fact, it is one of the top 10 most common types of cancer in Singapore.
With such prevalence, understanding individual risk factors is one of the proactive measures that an individual can take to safeguard their health. This includes:
When it comes to diagnosing Head and Neck cancer, the diagnostic procedure typically begins with a thorough examination:
Understanding the stage of head and neck cancer is crucial for both diagnosis, and treatment planning. It provides insight into how far the cancer has spread, and helps guide the next steps in your care. Head and neck cancers are classified into five stages, starting at Stage 0, and progressing to Stage IV.
Once the Head & Neck specialist has confirmed a diagnosis, and determined the characteristics of the tumour, which includes its staging, they will proceed to outline a treatment plan. Depending on how advanced the staging is, treatment may involve a standalone treatment plan or a combination of multiple treatments to better improve the outcomes.
One of the key aspects of treatment for head and neck cancer is rehabilitation. It is essential for improving quality of life post-treatment. This may include:
It should be emphasised that head and neck cancer is a highly preventable disease. Preventing head and neck cancer requires a proactive approach to health, and lifestyle choices. While some risk factors, like genetics, cannot be controlled, many can be addressed through informed decisions, and preventive measures. By understanding these steps, it will empower individuals to reduce their risk, and improve their overall well-being.
The use of tobacco, and excessive alcohol consumption are the leading preventable risk factors for head and neck cancers. Smoking, chewing tobacco, and prolonged alcohol use damage cells in the mouth, throat, and nearby tissues, significantly increasing cancer risk. By eliminating tobacco, and moderating alcohol intake, it will undoubtedly set you on the path towards prevention.
Speaking of the path towards prevention, support programmes such as nicotine replacement therapies, and counselling can provide essential tools to help individuals quit. Similarly, reducing alcohol consumption through moderation strategies or support groups can also contribute to lower cancer risk, and overall better health.
HPV is a major cause [9] of oropharyngeal cancers. As such, vaccination against HPV is a proven preventive measure, particularly for younger individuals as it helps protect against the strains of the virus that are commonly associated with cancer. Widespread vaccination programmes have shown promising results in reducing cancer incidence rates in both men, and women.
The primary step to lowering your risk of developing cancer is to undergo routine medical examinations, and screenings. This is due to the fact that both are indispensable for early detection, especially for individuals at high risk due to lifestyle choices, family history or occupational exposure. Regular check-ups with a healthcare provider enable doctors to identify any abnormal changes in the head and neck region before they progress into more severe conditions.
Remember; early detection often leads to more effective treatment, fewer complications, and better treatment outcomes. Medical screenings, such as visual inspections, imaging tests, and biopsies, play critical roles in diagnosing cancers at an early stage, particularly when they are most treatable.
In a nutshell, proactive health measures and awareness can make a significant difference in preventing head and neck cancers. In addition, recognising the symptoms early, such as persistent hoarseness, unexplained lumps or difficulty swallowing, combined with timely medical advice, are vital steps to safeguarding your health against head and neck cancers. By taking preventative actions, and making informed lifestyle changes, you can reduce your risk of developing the disease, and ensure a healthier future.
Schedule a consultation with us today for a comprehensive diagnosis and personalised treatment plan.
[1] Head and Neck Cancer: Symptoms and Risk Factors - HealthXchange. (n.d.). In www.healthxchange.sg. Retrieved January 22, 2025, from https://www.healthxchange.sg/cancer/head-neck-cancer/head-neck-cancer-symptoms-risk-factors
[2] Freedman ND, Schatzkin A, Leitzmann MF, Hollenbeck AR, Abnet CC. Alcohol and head and neck cancer risk in a prospective study. Br J Cancer. 2007 May 7;96(9):1469-74. doi: 10.1038/sj.bjc.6603713. Epub 2007 Mar 27. PMID: 17387340; PMCID: PMC2360181.
[3] Jethwa AR, Khariwala SS. Tobacco-related carcinogenesis in head and neck cancer. Cancer Metastasis Rev. 2017 Sep;36(3):411-423. doi: 10.1007/s10555-017-9689-6. PMID: 28801840; PMCID: PMC5709040.
[4] Li X, Koskinen AI, Hemminki O, Försti A, Sundquist J, Sundquist K, Hemminki K. Family History of Head and Neck Cancers. Cancers (Basel). 2021 Aug 16;13(16):4115. doi: 10.3390/cancers13164115. PMID: 34439270; PMCID: PMC8392405.
[5] Galati L, Chiocca S, Duca D, Tagliabue M, Simoens C, Gheit T, Arbyn M, Tommasino M. HPV and head and neck cancers: Towards early diagnosis and prevention. Tumour Virus Res. 2022 Dec;14:200245. doi: 10.1016/j.tvr.2022.200245. Epub 2022 Aug 13. PMID: 35973657; PMCID: PMC9420391.
[6] Clin B, Gramond C, Thaon I, Brochard P, Delva F, Chammings S, Gislard A, Laurent F, Paris C, Lacourt A, Pairon JC. Head and neck cancer and asbestos exposure. Occup Environ Med. 2022 Oct;79(10):690-696. doi: 10.1136/oemed-2021-108047. Epub 2022 Apr 7. PMID: 35393288; PMCID: PMC9484389.
[7] Langevin SM, McClean MD, Michaud DS, Eliot M, Nelson HH, Kelsey KT. Occupational dust exposure and head and neck squamous cell carcinoma risk in a population-based case-control study conducted in the greater Boston area. Cancer Med. 2013 Dec;2(6):978-86. doi: 10.1002/cam4.155. Epub 2013 Nov 4. PMID: 24403272; PMCID: PMC3892403.
[8] Carton M, Barul C, Menvielle G, Cyr D, Sanchez M, Pilorget C, Trétarre B, Stücker I, Luce D; ICARE Study Group. Occupational exposure to solvents and risk of head and neck cancer in women: a population-based case-control study in France. BMJ Open. 2017 Jan 9;7(1):e012833. doi: 10.1136/bmjopen-2016-012833. PMID: 28069619; PMCID: PMC5223686.
[9] Chaturvedi, A. K., Freedman, N. D., & Abnet, C. C. (2022). The Evolving Epidemiology of Oral Cavity and Oropharyngeal Cancers. Cancer research, 82(16), 2821–2823. https://doi.org/10.1158/0008-5472.CAN-22-2124
1 Farrer Park Station Road
#14-02 Connexion Singapore 217562
Monday - Friday 8:30am - 5:30pm
Saturday 8:30am - 12:30pm
Sunday & PHs Closed